Header Logo

J. Kevin Donahue MD

InstitutionUMass Chan Medical School
AddressUMass Chan Medical School
368 Plantation Street AS7-1043
Worcester MA 01605
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DivisionCardiovascular Medicine

    InstitutionMorningside Graduate School of Biomedical Sciences
    DepartmentMD/PhD Program

    InstitutionMorningside Graduate School of Biomedical Sciences
    DepartmentTranslational Science

    Collapse Biography 
    Collapse education and training
    Washington University in St Louis, Saint Louis, MO, United StatesBAChemistry
    Washington University School of Medicine, St. Louis, MO, United StatesMD

    Collapse Overview 
    Collapse overview

    Dr. Donahue completed undergraduate and medical education at Washington University in St. Louis, followed by an internal medicine residency at the Hospital of the University of Pennsylvania and fellowships in cardiology and cardiac electrophysiology at the Johns Hopkins University.  After completion of his medical training in 1999, Dr. Donahue served on the medical faculty at Johns Hopkins, where he attained the rank of Associate Professor prior to his 2005 relocation to Case Western Reserve University-MetroHealth Campus.  He was promoted to Professor at Case Western in 2011.  In 2013, Dr. Donahue relocated to the University of Massachusetts Medical School to start a position as Director of Electrophysiology Research. 

    Dr. Donahue’s primary research interests are the elucidation of mechanisms, and from that, the development of therapies for cardiac arrhythmias.  As a means to that end, the Donahue lab has developed several gene therapy methods and created novel animal models of cardiac arrhythmias.  The Donahue lab was first to show efficacy of gene therapy for a cardiac arrhythmia in a 12/2000 Nature Medicine publication documenting heart rate control in atrial fibrillation after atrioventricular nodal gene transfer of Gαi2.  More recently, the lab demonstrated complete elimination of post-myocardial infarction ventricular arrhythmias(Nature Medicine 12/2006) and reduction in atrial fibrillation vulnerability in porcine disease models after potassium channel and connexin gene transfer.  Ongoing interests include the investigation of mechanisms for ischemic and post-infarct ventricular arrhythmias and chronic atrial fibrillation, the development of improved gene delivery methods, and the use of these methods for arrhythmia gene therapy.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tran KV, Donahue JK. Identifying the Role of Lipomatous Metaplasia in Ventricular Tachycardia Mechanism for Nonischemic Cardiomyopathy. JACC Clin Electrophysiol. 2024 Jun; 10(6):1147-1149. PMID: 38819349.
    2. Donahue JK, Chrispin J, Ajijola OA. Mechanism of Ventricular Tachycardia Occurring in Chronic Myocardial Infarction Scar. Circ Res. 2024 02 02; 134(3):328-342. PMID: 38300981.
      Citations:    Fields:    Translation:Humans
    3. Donahue JK. Editorial commentary: The mundane and the profound of QT prolongation in the opioid abuse crisis. Trends Cardiovasc Med. 2024 Jul; 34(5):286-287. PMID: 37419255.
      Citations:    Fields:    
    4. Benson JM, Wang G, Hutt JA, Wu G, Kaminsky SM, Cram S, Barur R, Donahue JK. Preclinical safety and biodistribution assessment of Ad-KCNH2-G628S administered via atrial painting in New Zealand white rabbits. Basic Clin Pharmacol Toxicol. 2023 Aug; 133(2):179-193. PMID: 37177881.
      Citations:    Fields:    Translation:HumansAnimals
    5. Callans DJ, Donahue JK. Repolarization Heterogeneity in Human Post-Infarct Ventricular Tachycardia. JACC Clin Electrophysiol. 2022 06; 8(6):713-718. PMID: 35738846.
      Citations: 4     Fields:    Translation:HumansAnimals
    6. Kelemen K, Greener ID, Wan X, Parajuli S, Donahue JK. Heterogeneous repolarization creates ventricular tachycardia circuits in healed myocardial infarction scar. Nat Commun. 2022 02 11; 13(1):830. PMID: 35149693.
      Citations: 8     Fields:    Translation:HumansAnimals
    7. Mo W, Donahue JK. Atrial Gene Painting in Large Animal Model of Atrial Fibrillation. Methods Mol Biol. 2022; 2573:205-216. PMID: 36040597.
      Citations:    Fields:    Translation:Animals
    8. Donahue JK. Editorial commentary: A careful approach to gene editing. Trends Cardiovasc Med. 2021 08; 31(6):349-350. PMID: 32860890.
      Citations:    Fields:    Translation:Humans
    9. Vaze A, Tran KV, Tanriverdi K, Sardana M, Lessard D, Donahue JK, Barton B, Aurigemma G, Lubitz SA, Lin H, Nasr GH, Mandapati A, Benjamin EJ, Vasan RS, Freedman JE, McManus DD. Relations between plasma microRNAs, echocardiographic markers of atrial remodeling, and atrial fibrillation: Data from the Framingham Offspring study. PLoS One. 2020; 15(8):e0236960. PMID: 32813736.
      Citations: 5     Fields:    Translation:Humans
    10. Liu Z, Finet JE, Wolfram JA, Anderson ME, Ai X, Donahue JK. Calcium/calmodulin-dependent protein kinase II causes atrial structural remodeling associated with atrial fibrillation and heart failure. Heart Rhythm. 2019 07; 16(7):1080-1088. PMID: 30654134.
      Citations: 17     Fields:    Translation:AnimalsCells
    11. Donahue JK. Editorial commentary: Epigenetics and cardiovascular disease-From concept to reality. Trends Cardiovasc Med. 2018 07; 28(5):320-321. PMID: 29496409.
      Citations:    Fields:    Translation:Humans
    12. Donahue JK. Sequencing of uncertain significance. J Cardiovasc Electrophysiol. 2018 01; 29(1):105-106. PMID: 29120076.
      Citations:    Fields:    Translation:Humans
    13. Finet JE, Wan X, Donahue JK. Fusion of Anthopleurin-B to AAV2 increases specificity of cardiac gene transfer. Virology. 2018 01 01; 513:43-51. PMID: 29032346.
      Citations:    Fields:    Translation:HumansCells
    14. Donahue JK. Current state of the art for cardiac arrhythmia gene therapy. Pharmacol Ther. 2017 Aug; 176:60-65. PMID: 28642118.
      Citations: 5     Fields:    Translation:HumansAnimals
    15. Liu Z, Hutt JA, Rajeshkumar B, Azuma Y, Duan KL, Donahue JK. Preclinical efficacy and safety of KCNH2-G628S gene therapy for postoperative atrial fibrillation. J Thorac Cardiovasc Surg. 2017 11; 154(5):1644-1651.e8. PMID: 28676183.
      Citations: 10     Fields:    Translation:HumansAnimals
    16. Donahue JK. Gene Therapy for Post-infarction Ventricular Tachycardia. Methods Mol Biol. 2017; 1521:307-321. PMID: 27910059.
      Citations: 1     Fields:    Translation:Animals
    17. Sardana M, Ogunsua AA, Spring M, Shaikh A, Asamoah O, Stokken G, Browning C, Ennis C, Donahue JK, Rosenthal LS, Floyd KC, Aurigemma GP, Parikh NI, McManus DD. Association of Left Atrial Function Index With Late Atrial Fibrillation Recurrence after Catheter Ablation. J Cardiovasc Electrophysiol. 2016 12; 27(12):1411-1419. PMID: 27569695.
      Citations: 8     Fields:    Translation:Humans
    18. Donahue JK. Cardiac gene therapy: a call for basic methods development. Lancet. 2016 Mar 19; 387(10024):1137-9. PMID: 26806516.
      Citations: 4     Fields:    Translation:HumansCells
    19. Donahue JK. Biological Therapies for Atrial Fibrillation: Ready for Prime Time? J Cardiovasc Pharmacol. 2016 Jan; 67(1):19-25. PMID: 26222989.
      Citations: 5     Fields:    Translation:HumansAnimals
    20. Shaikh AY, Esa N, Martin-Doyle W, Kinno M, Nieto I, Floyd KC, Browning C, Ennis C, Donahue JK, Rosenthal LS, McManus DD. Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation. Crit Pathw Cardiol. 2015 Dec; 14(4):157-65. PMID: 26569657.
      Citations: 4     Fields:    Translation:Humans
    21. Nassal MM, Werdich AA, Wan X, Hoshi M, Desch?nes I, Rosenbaum DS, Donahue JK. Phosphorylation at Connexin43 Serine-368 Is Necessary for Myocardial Conduction During Metabolic Stress. J Cardiovasc Electrophysiol. 2016 Jan; 27(1):110-9. PMID: 26459193.
      Citations: 6     Fields:    Translation:AnimalsCells
    22. Liu Z, Donahue JK. The Use of Gene Therapy for Ablation of Atrial Fibrillation. Arrhythm Electrophysiol Rev. 2014 Nov; 3(3):139-44. PMID: 26835081.
    23. McManus DD, Tanriverdi K, Lin H, Esa N, Kinno M, Mandapati D, Tam S, Okike ON, Ellinor PT, Keaney JF, Donahue JK, Benjamin EJ, Freedman JE. Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study). Heart Rhythm. 2015 Jan; 12(1):3-10. PMID: 25257092.
      Citations: 56     Fields:    Translation:Humans
    24. Panda NC, Zuckerman ST, Mesubi OO, Rosenbaum DS, Penn MS, Donahue JK, Alsberg E, Laurita KR. Improved conduction and increased cell retention in healed MI using mesenchymal stem cells suspended in alginate hydrogel. J Interv Card Electrophysiol. 2014 Nov; 41(2):117-27. PMID: 25234602.
      Citations: 22     Fields:    Translation:AnimalsCells
    25. Jennings MM, Donahue JK. Connexin Remodeling Contributes to Atrial Fibrillation. J Atr Fibrillation. 2013 Aug-Sep; 6(2):839. PMID: 28496873.
    26. Wolfram JA, Donahue JK. Gene therapy to treat cardiovascular disease. J Am Heart Assoc. 2013 Aug 20; 2(4):e000119. PMID: 23963752.
      Citations: 25     Fields:    Translation:HumansAnimals
    27. Ibrahim MA, Do DV, Sepah YJ, Shah SM, Van Anden E, Hafiz G, Donahue JK, Rivers R, Balkissoon J, Handa JT, Campochiaro PA, Nguyen QD. Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin A-4 phosphate. BMC Pharmacol Toxicol. 2013 Jan 14; 14:7. PMID: 23316779.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    28. Greener ID, Sasano T, Wan X, Igarashi T, Strom M, Rosenbaum DS, Donahue JK. Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction. J Am Coll Cardiol. 2012 Sep 18; 60(12):1103-10. PMID: 22883636.
      Citations: 54     Fields:    Translation:Animals
    29. Igarashi T, Finet JE, Takeuchi A, Fujino Y, Strom M, Greener ID, Rosenbaum DS, Donahue JK. Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation. Circulation. 2012 Jan 17; 125(2):216-25. PMID: 22158756.
      Citations: 92     Fields:    Translation:Animals
    30. Swaminathan PD, Purohit A, Soni S, Voigt N, Singh MV, Glukhov AV, Gao Z, He BJ, Luczak ED, Joiner ML, Kutschke W, Yang J, Donahue JK, Weiss RM, Grumbach IM, Ogawa M, Chen PS, Efimov I, Dobrev D, Mohler PJ, Hund TJ, Anderson ME. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest. 2011 Aug; 121(8):3277-88. PMID: 21785215.
      Citations: 131     Fields:    Translation:HumansAnimals
    31. Greener I, Donahue JK. Gene therapy strategies for cardiac electrical dysfunction. J Mol Cell Cardiol. 2011 May; 50(5):759-65. PMID: 20696170.
      Citations: 10     Fields:    Translation:Humans
    32. Amit G, Kikuchi K, Greener ID, Yang L, Novack V, Donahue JK. Selective molecular potassium channel blockade prevents atrial fibrillation. Circulation. 2010 Jun 01; 121(21):2263-70. PMID: 20479154.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    33. Donahue JK. Advice for management of the long-QT patient. J Cardiovasc Electrophysiol. 2010 Aug 01; 21(8):902-4. PMID: 20455972.
      Citations:    Fields:    Translation:Humans
    34. Sasano T, Kelemen K, Greener ID, Donahue JK. Ventricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapy. Heart Rhythm. 2009 Aug; 6(8 Suppl):S91-7. PMID: 19631912.
      Citations: 17     Fields:    Translation:HumansAnimals
    35. Finet JE, Rosenbaum DS, Donahue JK. Information learned from animal models of atrial fibrillation. Cardiol Clin. 2009 Feb; 27(1):45-54, viii. PMID: 19111763.
      Citations: 8     Fields:    Translation:HumansAnimals
    36. Donahue JK. Novel strategy to reduce sudden-death risk in the healing phase after myocardial infarction. Circulation. 2009 Jan 06; 119(1):6-8. PMID: 19103983.
      Citations:    Fields:    Translation:Humans
    37. Amit G, Qin H, Donahue JK. Biological therapies for atrial fibrillation. J Cardiovasc Pharmacol. 2008 Sep; 52(3):222-7. PMID: 18806602.
      Citations: 3     Fields:    Translation:HumansAnimals
    38. Lehnart SE, Ackerman MJ, Benson DW, Brugada R, Clancy CE, Donahue JK, George AL, Grant AO, Groft SC, January CT, Lathrop DA, Lederer WJ, Makielski JC, Mohler PJ, Moss A, Nerbonne JM, Olson TM, Przywara DA, Towbin JA, Wang LH, Marks AR. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation. 2007 Nov 13; 116(20):2325-45. PMID: 17998470.
      Citations: 81     Fields:    Translation:Humans
    39. Donahue JK, Sasano T, Kelemen K. Gene therapy approaches to ventricular tachyarrhythmias. J Electrocardiol. 2007 Nov-Dec; 40(6 Suppl):S187-91. PMID: 17993320.
      Citations: 2     Fields:    Translation:HumansAnimals
    40. Ashikaga H, Sasano T, Dong J, Zviman MM, Evers R, Hopenfeld B, Castro V, Helm RH, Dickfeld T, Nazarian S, Donahue JK, Berger RD, Calkins H, Abraham MR, Marb?n E, Lardo AC, McVeigh ER, Halperin HR. Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation. Circ Res. 2007 Oct 26; 101(9):939-47. PMID: 17916777.
      Citations: 66     Fields:    Translation:Animals
    41. Donahue JK. Gene therapy for cardiac arrhythmias: a dream soon to come true? J Cardiovasc Electrophysiol. 2007 May; 18(5):553-9. PMID: 17456137.
      Citations: 1     Fields:    Translation:Humans
    42. Sasano T, Kikuchi K, McDonald AD, Lai S, Donahue JK. Targeted high-efficiency, homogeneous myocardial gene transfer. J Mol Cell Cardiol. 2007 May; 42(5):954-61. PMID: 17484913.
      Citations: 41     Fields:    Translation:Animals
    43. Kapur NK, Deming CB, Kapur S, Bian C, Champion HC, Donahue JK, Kass DA, Rade JJ. Hemodynamic modulation of endocardial thromboresistance. Circulation. 2007 Jan 02; 115(1):67-75. PMID: 17190863.
      Citations: 15     Fields:    Translation:Animals
    44. Sasano T, McDonald AD, Kikuchi K, Donahue JK. Molecular ablation of ventricular tachycardia after myocardial infarction. Nat Med. 2006 Nov; 12(11):1256-8. PMID: 17072309.
      Citations: 58     Fields:    Translation:Animals
    45. Donahue JK. Gender and the heart. Heart Rhythm. 2006 Jul; 3(7):840-1. PMID: 16818218.
      Citations:    Fields:    Translation:HumansAnimals
    46. Tandri H, Griffith LS, Tang T, Nasir K, Zardkoohi O, Reddy CV, Capps M, Calkins H, Donahue JK. Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm. 2006 Jul; 3(7):762-8. PMID: 16818202.
      Citations: 4     Fields:    Translation:Humans
    47. Henrikson CA, Brinker JA, Donahue JK. Temporary placement of a defibrillating lead in the treatment of infection and ventricular tachycardia. Heart Rhythm. 2006 Feb; 3(2):222-4. PMID: 16443540.
      Citations:    Fields:    Translation:HumansCells
    48. Reynolds DW, Chen PS, Deal BJ, Donahue JK, Ellenbogen KA, Epstein AE, Friedman PA, Hammill SC, Hohnloser SH, Kanter RJ, Lindsay BD, Natale A, Saffitz J, Stevenson WG. Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4-7, 2005, New Orleans, Louisiana. Heart Rhythm. 2005 Sep; 2(9):1025-33. PMID: 16171766.
      Citations:    Fields:    Translation:Humans
    49. Donahue JK, Kikuchi K, Sasano T. Gene therapy for cardiac arrhythmias. Trends Cardiovasc Med. 2005 Aug; 15(6):219-24. PMID: 16182132.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    50. Donahue JK, Bauer A, Kikuchi K, Sasano T. Modification of cellular communication by gene transfer. Ann N Y Acad Sci. 2005 Jun; 1047:157-65. PMID: 16093493.
      Citations: 1     Fields:    Translation:HumansAnimals
    51. Roguin A, Donahue JK, Bomma CS, Bluemke DA, Halperin HR. Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2005 Apr; 28(4):336-8. PMID: 15826272.
      Citations: 8     Fields:    Translation:Humans
    52. Kikuchi K, McDonald AD, Sasano T, Donahue JK. Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer. Circulation. 2005 Jan 25; 111(3):264-70. PMID: 15642761.
      Citations: 53     Fields:    Translation:AnimalsCells
    53. Bauer A, McDonald AD, Nasir K, Peller L, Rade JJ, Miller JM, Heldman AW, Donahue JK. Inhibitory G protein overexpression provides physiologically relevant heart rate control in persistent atrial fibrillation. Circulation. 2004 Nov 09; 110(19):3115-20. PMID: 15505099.
      Citations: 30     Fields:    Translation:AnimalsCells
    54. Murata M, Cingolani E, McDonald AD, Donahue JK, Marb?n E. Creation of a genetic calcium channel blocker by targeted gem gene transfer in the heart. Circ Res. 2004 Aug 20; 95(4):398-405. PMID: 15242970.
      Citations: 40     Fields:    Translation:AnimalsCells
    55. Eldadah ZA, Donahue JK. Successful implantable cardioverter defibrillator placement in an ambulatory patient without thoracic venous access. J Cardiovasc Electrophysiol. 2004 Jun; 15(6):716-8. PMID: 15175069.
      Citations: 1     Fields:    Translation:Humans
    56. Donahue JK. Gene therapy for cardiac arrhythmias. Ann N Y Acad Sci. 2004 May; 1015:332-7. PMID: 15201172.
      Citations: 1     Fields:    Translation:Humans
    57. Bauer A, McDonald AD, Donahue JK. Pathophysiological findings in a model of persistent atrial fibrillation and severe congestive heart failure. Cardiovasc Res. 2004 Mar 01; 61(4):764-70. PMID: 14985073.
      Citations: 29     Fields:    Translation:Animals
    58. Bauer A, Donahue JK, Voss F, Becker R, Kraft P, Senges JC, Kelemen K, Katus HA, Schoels W. Pro- and antiarrhythmic effects of fast cardiac pacing in a canine model of acquired long QT syndrome. Naunyn Schmiedebergs Arch Pharmacol. 2004 Apr; 369(4):447-54. PMID: 14985939.
      Citations:    Fields:    Translation:Animals
    59. Donahue JK, Bauer A, Kikuchi K, McDonald AD. Gene transfer techniques for cardiac arrhythmias. Ann Med. 2004; 36 Suppl 1:98-105. PMID: 15176431.
      Citations:    Fields:    Translation:HumansCells
    60. Tomaselli GF, Donahue JK. Somatic gene transfer and cardiac arrhythmias: problems and prospects. J Cardiovasc Electrophysiol. 2003 May; 14(5):547-50. PMID: 12776876.
      Citations: 1     Fields:    Translation:Humans
    61. Lehnart SE, Donahue JK. Coronary perfusion cocktails for in vivo gene transfer. Methods Mol Biol. 2003; 219:213-8. PMID: 12597011.
      Citations: 3     Fields:    Translation:AnimalsCells
    62. Janssen PM, Schillinger W, Donahue JK, Zeitz O, Emami S, Lehnart SE, Weil J, Eschenhagen T, Hasenfuss G, Prestle J. Intracellular beta-blockade: overexpression of Galpha(i2) depresses the beta-adrenergic response in intact myocardium. Cardiovasc Res. 2002 Aug 01; 55(2):300-8. PMID: 12123769.
      Citations: 8     Fields:    Translation:AnimalsCells
    63. Neyroud N, Nuss HB, Leppo MK, Marb?n E, Donahue JK. Gene delivery to cardiac muscle. Methods Enzymol. 2002; 346:323-34. PMID: 11883077.
      Citations: 1     Fields:    Translation:AnimalsCells
    64. Nagata K, Marb?n E, Lawrence JH, Donahue JK. Phosphodiesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium. J Mol Cell Cardiol. 2001 Mar; 33(3):575-80. PMID: 11181024.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    65. Donahue JK, Heldman AW, Fraser H, McDonald AD, Miller JM, Rade JJ, Eschenhagen T, Marb?n E. Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med. 2000 Dec; 6(12):1395-8. PMID: 11100126.
      Citations: 54     Fields:    Translation:AnimalsCells
    66. Donahue JK, Kikkawa K, Thomas AD, Marban E, Lawrence JH. Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin. Gene Ther. 1998 May; 5(5):630-4. PMID: 9797867.
      Citations: 25     Fields:    Translation:AnimalsCells
    67. Donahue JK, Kikkawa K, Johns DC, Marban E, Lawrence JH. Ultrarapid, highly efficient viral gene transfer to the heart. Proc Natl Acad Sci U S A. 1997 Apr 29; 94(9):4664-8. PMID: 9114048.
      Citations: 35     Fields:    Translation:AnimalsCells
    Donahue's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (269)
    Co-Authors (11)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors